GlobalData on MSN15h
Shionogi awarded $375m from HHS for preventative Covid-19 injectableShionogi’s S-892216 is being developed as a pre-exposure prophylaxis (PrEP) drug for Covid-19. Credit: seksan Mongkhonkhamsao ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback